Suppr超能文献

非水溶剂中的蛋白粉末混悬剂用于治疗性蛋白的递送。

Powder suspensions in non-aqueous vehicles for delivery of therapeutic proteins.

机构信息

Ludwig-Maximilians-Universität München, Department of Pharmacy, Pharmaceutical Technology and Biopharmceutics, Butenandtstraße 5, D-81377 München, Germany; AbbVie Deutschland GmbH, Knollstraße 50, D-67061 Ludwigshafen, Germany(1).

Novaliq GmbH, Im Neuenheimer Feld 515, D-69120 Heidelberg, Germany; Merck KGaA, Frankfurter Straße 250, D-64293 Darmstadt, Germany(1).

出版信息

Eur J Pharm Biopharm. 2021 Apr;161:37-49. doi: 10.1016/j.ejpb.2021.01.014. Epub 2021 Feb 4.

Abstract

Formulating biopharmaceuticals is a challenging task due to their complex and sensitive nature. Protein drugs are typically marketed either as an aqueous solution or as a lyophilizate. Usually aqueous solutions are preferred as neither drying nor reconstitution are required. But it may be unfeasible if the protein features low stability. An interesting alternative to avoid at least reconstitution are protein powder suspensions in non-aqueous vehicles. Such formulations combine the ready-to-use approach with the high protein stability in the solid state. Additionally, protein powder suspensions offer a potentially lower viscosity compared to aqueous solutions at high protein concentrations. Besides injection, other application routes might also benefit from the protein powder approach such as topical or inhalational delivery. Protein powders, which can be dispersed in the non-aqueous suspension vehicle, are usually prepared by spray-drying or freeze-drying with an additional milling step, but other techniques have also been described in literature. An ideal powder preparation technique results in minimum protein damage and yields particle sizes in the lower micrometre range and homogeneous particle size distribution enabling subcutaneous or intramuscular injection through hypodermic needles. As suspension vehicles traditional non-aqueous injectable liquids, such as plant oils, may be selected. But they show an inherent high viscosity, which can lead to unacceptable glide forces during injection. Furthermore, the vehicle should provide high product stability with respect to protein integrity and suspension resuspendability. This review will describe how proteins can be formulated as protein powder suspensions in non-aqueous vehicles for subcutaneous injection including potential vehicles, protein powder preparation techniques, protein and suspension physical stability, as well as the use in the field of high concentration protein formulations.

摘要

由于生物制药的复杂和敏感性,其制剂是一项具有挑战性的任务。蛋白质药物通常以水溶液或冻干物的形式上市。通常首选水溶液,因为既不需要干燥也不需要复溶。但是,如果蛋白质的稳定性较低,则可能不可行。一种有趣的替代方法是避免至少复溶,即将蛋白质粉末混悬于非水载体中。这些制剂将即用型方法与固体状态下的高蛋白质稳定性结合在一起。此外,与高蛋白质浓度的水溶液相比,蛋白质粉末混悬剂具有潜在的较低黏度。除了注射,其他应用途径也可能受益于蛋白质粉末方法,如局部或吸入给药。可以分散在非水混悬液载体中的蛋白质粉末通常通过喷雾干燥或冷冻干燥并增加研磨步骤来制备,但文献中也描述了其他技术。理想的粉末制备技术可将蛋白质损伤降至最低,并产生粒径处于较低微米范围内且具有均匀粒径分布的颗粒,从而可通过皮下或肌肉内注射针进行皮下或肌肉内注射。可以选择传统的非水注射用液体作为混悬液载体,例如植物油。但是它们表现出固有的高黏度,这可能导致注射时不可接受的滑动力。此外,该载体应在蛋白质完整性和混悬液再混悬性方面提供高产品稳定性。本综述将描述如何将蛋白质制剂为非水载体中的蛋白质粉末混悬剂用于皮下注射,包括潜在的载体、蛋白质粉末制备技术、蛋白质和混悬液物理稳定性以及在高浓度蛋白质制剂领域的应用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验